Cellectis SA (CLLS)
3.41
+0.03
(+0.89%)
USD |
NASDAQ |
Apr 02, 16:00
3.49
+0.08
(+2.35%)
After-Hours: 20:00
Cellectis Total Liabilities (Quarterly) : 255.58M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 64.95M |
| EDAP TMS SA | 59.58M |
| Sanofi | -- |
| Akari Therapeutics Plc | 19.67M |
| Biodexa Pharmaceuticals Plc | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 331.48M |
| Shareholders Equity (Quarterly) | 75.90M |
| Debt to Equity Ratio | 1.580 |
| Current Ratio | 1.621 |
| Net Debt Paydown Yield | -0.32% |